Major clinical data Right. Have you any idea of the past?
1. NSCLC "Clinical and immunogenicity data from Part B cohort"
How many patients in the cohort? 2 or 3? Does this type of data prove efficacy? When is the earliest, if everything goes perfect, that we can expect a HOT NDA?
2. Prostate "Initiate clinical study"
Isn't this just initiating brand new expenses? So much for the runway to 2021.
3. PSA "Announce program next steps"
Wow, and announcement! Probably akin to the Amgen bailing announcement, the NEO shelving announcement, the AXAL shelving announcement, the non-announcement of the AXAL unblinded results, and the announcement of the poison pill management bonuses upon change of control
News 
Market Data 
Discover 
